# Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion

> **NCT04166331** · PHASE3 · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 136 (actual)

## Conditions studied

- Sepsis
- Cardiomyopathies
- Hypoperfusion
- Left Ventricular Systolic Dysfunction

## Interventions

- **DRUG:** Placebos
- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT04166331
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-20
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04166331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04166331, "Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04166331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*